Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
D-Serine | hsa00220 | Arginine biosynthesis | 1.50E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | D-Serine | hsa00330 | Arginine and proline metabolism | 4.10E-02 | 1 | P17707 | AMD1 | More | | D-Serine | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | | D-Serine | hsa00600 | Sphingolipid metabolism | 2.19E-02 | 2 | P07602, Q13510 | PSAP, ASAH1 | More | | D-Serine | hsa00670 | One carbon pool by folate | 3.91E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | D-Serine | hsa00830 | Retinol metabolism | 4.10E-02 | 1 | P00325 | ADH1B | More | | D-Serine | hsa01100 | Metabolic pathways | 3.37E-02 | 36 | P05089, Q9UJ14, P15104, O14986, P48426, Q14642, Q96DU7, P07195, Q08828, Q02153, Q16875, O43286, O43451, Q86XP1, Q14739, Q9UHK6, P11511, Q86VZ5, Q08477, P15907, Q9UNP4, Q9H4F1, P32321, P60891, P49448, P15586, P00352, Q9BPW9, P43490, P46976, P05166, P13073, P05496, O15239, O15047, Q9NVH6 | ARG1, GGTL3, GLUL, PIP5K1B, PIP4K2A, INPP5A, ITPKC, LDHB, ADCY1, GUCY1B3, PFKFB3, B4GALT5, MGAM, DGKH, LBR, AMACR, CYP19A1, SGMS1, CYP4F3, ST6GAL1, ST3GAL5, ST6GALNAC4, DCTD, PRPS1, GLUD2, GNS, ALDH1A1, DHRS9, PBEF1, GYG1, PCCB, COX4I1, ATP5G1, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05089 | ARG1 | Arginase-1 | 0.826 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.769 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15104 | GLUL | Glutamine synthetase | 0.834 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O14986 | PIP5K1B | Phosphatidylinositol 4-phosphate 5-kinase type-1 beta | 0.806 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.725 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q14642 | INPP5A | Inositol polyphosphate-5-phosphatase A | 0.758 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | -0.816 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P07195 | LDHB | L-lactate dehydrogenase B chain | -0.75 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.785 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.834 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.861 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O43451 | MGAM | Maltase-glucoamylase | 0.745 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.757 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q14739 | LBR | Delta(14)-sterol reductase LBR | 0.73 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.736 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P11511 | CYP19A1 | Aromatase | -0.706 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.733 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.832 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.936 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | 0.758 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P32321 | DCTD | Deoxycytidylate deaminase | -0.774 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | -0.769 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | -0.895 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15586 | GNS | N-acetylglucosamine-6-sulfatase | 0.716 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | -0.808 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.821 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.749 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P46976 | GYG1 | Glycogenin-1 | 0.845 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05166 | PCCB | Propionyl-CoA carboxylase beta chain, mitochondrial | 0.781 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.713 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.745 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | 0.809 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.719 |
| D-Serine | hsa03013 | RNA transport | 4.72E-02 | 7 | O14980, Q09161, P35658, P47813, Q14152, O75822, P51114 | XPO1, NCBP1, NUP214, EIF1AX, EIF3A, EIF3J, FXR1 | More | | D-Serine | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | | D-Serine | hsa04060 | Cytokine-cytokine receptor interaction | 4.33E-02 | 11 | P27930, P14778, P01584, Q13651, Q9HBE5, Q9UBD3, P47992, P09341, P32248, P18510, P01730 | IL1R2, IL1R1, IL1B, IL10RA, IL21R, XCL2, XCL1, CXCL1, CCR7, IL1RN, CD4 | More | | D-Serine | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | | D-Serine | hsa04151 | PI3K-Akt signaling pathway | 2.51E-02 | 16 | P21860, P43657, P01106, P27348, O14944, Q9GZP0, P07900, P62873, P50151, P13612, P26012, P24821, Q16363, P22105, Q99941, P18848 | ERBB3, P2RY5, MYC, YWHAQ, EREG, PDGFD, HSP90AA1, GNB1, GNG10, ITGA4, ITGB8, TNC, LAMA4, TNXB, CREBL1, ATF4 | More | | D-Serine | hsa04270 | Vascular smooth muscle contraction | 2.01E-02 | 3 | P0DP24, P35579, P35318 | CALM2, MYH9, ADM | More | | D-Serine | hsa04512 | ECM-receptor interaction | 4.68E-02 | 5 | Q16363, P24821, P22105, P13612, P26012 | LAMA4, TNC, TNXB, ITGA4, ITGB8 | More | | D-Serine | hsa04621 | NOD-like receptor signaling pathway | 4.31E-02 | 4 | P01375, P59665, P59666, P12838 | TNF, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | D-Serine | hsa04640 | Hematopoietic cell lineage | 6.74E-03 | 10 | P13612, P14778, P27930, P25063, P07766, P09693, P01732, P01730, P13765, P01584 | ITGA4, IL1R1, IL1R2, CD24, CD3E, CD3G, CD8A, CD4, HLA-DOB, IL1B | More | | D-Serine | hsa04658 | Th1 and Th2 cell differentiation | 3.62E-04 | 11 | Q04759, P07766, P20963, P09693, P01730, P06239, P23771, Q9UL17, P46531, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, GATA3, TBX21, NOTCH1, HLA-DOB, RUNX3 | More | | D-Serine | hsa04659 | Th17 cell differentiation | 8.31E-05 | 13 | Q04759, P01730, P06239, P13765, P14778, Q9HBE5, Q9UL17, P23771, P01584, P07900, P07766, P09693, P20963 | PRKCQ, CD4, LCK, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, IL1B, HSP90AA1, CD3E, CD3G, CD247 | More | | D-Serine | hsa04660 | T cell receptor signaling pathway | 4.36E-03 | 10 | Q04759, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239 | PRKCQ, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK | More | | D-Serine | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.28E-02 | 6 | P14778, P01584, Q08828, Q13557, P24723, Q04759 | IL1R1, IL1B, ADCY1, CAMK2D, PRKCH, PRKCQ | More | | D-Serine | hsa04934 | Cushing syndrome | 2.63E-02 | 6 | Q99941, P18848, Q08828, O15169, Q13557, O00170 | CREBL1, ATF4, ADCY1, AXIN1, CAMK2D, AIP | More | | D-Serine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | D-Serine | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.10E-02 | 1 | O00141 | SGK | More | | D-Serine | hsa05032 | Morphine addiction | 1.09E-02 | 2 | P78334, P32298 | GABRE, GRK4 | More | | D-Serine | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | | D-Serine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | D-Serine | hsa05146 | Amoebiasis | 7.62E-03 | 9 | P01584, Q16363, P09341, P14778, P27930, P05089, Q08828, P12814, P08311 | IL1B, LAMA4, CXCL1, IL1R1, IL1R2, ARG1, ADCY1, ACTN1, CTSG | More | | D-Serine | hsa05150 | Staphylococcus aureus infection | 1.83E-02 | 3 | P59665, P59666, P12838 | DEFA1; DEFA1B, DEFA3, DEFA4 | More | | D-Serine | hsa05171 | Coronavirus disease - COVID-19 | 4.47E-02 | 2 | Q9UHA3, O14786 | RSL24D1, NRP1 | More | | D-Serine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.83E-02 | 7 | O95267, P07766, P20963, P09693, P06239, Q04759, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, PRKCQ, CD4 | More | | D-Serine | hsa05321 | Inflammatory bowel disease | 4.68E-02 | 5 | P13765, Q9UL17, P23771, P01584, Q9HBE5 | HLA-DOB, TBX21, GATA3, IL1B, IL21R | More | | D-Serine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | D-Serine | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | D-Serine | hsa05340 | Primary immunodeficiency | 3.99E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | |